68Ga-PSMA-11与18F-Fluciclovine PET/CT中的少突胶质细胞瘤
本文报道一例83岁男性,已知少突胶质细胞瘤且前列腺癌生化复发,68Ga-PSMA-11与18F-fluciclovine PET/CT均显示脑内高局灶性摄取。提示这两种用于前列腺癌复发的示踪剂在脑肿瘤中也可出现摄取,需注意判读。
要点
- 68Ga-PSMA-11与18F-fluciclovine PET/CT在少突胶质细胞瘤中可表现为脑内高局灶性摄取。
- 前列腺癌生化复发患者行这两种PET/CT时,脑内高摄取不应默认归因于前列腺癌转移。
- 判读时应结合已知脑肿瘤病史,避免将脑肿瘤摄取误判为转移灶。
核心结论
- 68Ga-PSMA-11与18F-fluciclovine PET/CT可在少突胶质细胞瘤患者脑内显示高局灶性摄取。
研究设计与样本
- 本文为个案报道,对象为一名83岁已知少突胶质细胞瘤且前列腺癌生化复发的男性患者。
主要发现
- 该患者68Ga-PSMA-11与18F-fluciclovine PET/CT均显示脑内高局灶性摄取。
临床怎么用
- 前列腺癌患者行68Ga-PSMA-11或18F-fluciclovine PET/CT时,若脑内出现高局灶性摄取,应结合已知脑肿瘤病史综合判读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Prostate cancer (PC) is one of the most common cancers affecting men worldwide, with a high recurrence rate after therapy. 68Ga-PSMA-11 and 18F-fluciclovine are PET imaging tracers for the detection of recurrence sites in PC patients. 68Ga-PSMA-11 is a membrane antigen overexpressed by tumor cells, whereas 18F-fluciclovine targets increased amino acid transporter in the membrane of cancer cells. We report a case of an 83-year-old man with known oligodendroglioma and biochemically recurrent PC who shows a high focal 68Ga-PSMA-11 and 18F-fluciclovine uptake in the brain.
引用
- Pernthaler B, Nazerani Hooshmand T, Igrec J, et al. Oligodendroglioma in 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT. Clin Nucl Med. 2021. PMID: 33086280. doi:10.1097/RLU.0000000000003347
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。